GHRH analog is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-05-29. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
== History == The ridge was named in 1907 by Mary Schäffer, the same year that Jasper National Park was established. In her book, "A Hunter of Peace," Mary wrote: "A short distance beyond the rock-slide and on the river's right, begins a low, rocky ridge, which for length and unadulterated ugliness cannot be beaten. We trailed it for a day and a half and then named it The Endless Chain, well named too, for on reaching the Athabasca shores, we found that it still stretched on in an unbroken line for miles down the river." The toponym was officially adopted in 1947 by the Geographical Names Board of Canada.
Leela Kapila, Consultant Paediatric Surgeon, University Hospital, Nottingham. For services to Medicine. Fergal Patrick Keane, BBC Foreign Correspondent. For services to Television Journalism. John Kelly. For services to Agriculture and to Banking. John Charles King, Chief Executive, Security Facilities Executive, Cabinet Office (Office of Public Service). John Kirkham, lately Grade 6, Ministry of Agriculture, Fisheries and Food. Glen Kirton. For services to Association Football, particularly Euro 96. Alice Elizabeth Audrey Lamb. For services to Education. Penelope Lambert. For services to the Board of Visitors Her Majesty's Prison Whitemoor. Michael John Leech, Principal, Stevenson College, Edinburgh. For services to Education. Gilberte-Marie Brunsdon-Lenaerts. For services to Anglo-Belgian Relations. Ann Molyneux Lewis, lately President, Royal Pharmaceutical Society of Great Britain. For services to the Pharmacy Profession. Kenneth Lewis, Chairman, Horizon NHS Trust. For services to Health Care. Timothy Lewis. For services to the Police. Ian Stanley Cash Linney. For services to the community in Nottinghamshire. James Logan. For services to Aviation. Angus Victor Peck MacKay, Physician Superintendent, Argyll and Bute Hospital. For services to Medicine. William Alexander Lee MacKay, Vice Chairman, Management and Human Resources Committee, Association of District Councils. For services to Local Government. Lieutenant Colonel John Pierce Margarson, . For services to Soldiers' Sailors' and Airmens' Families Association in Clwyd.
==== Party name ==== The SPGB had been using the short form of its name, the Socialist Party, for publicity purposes as far back as 1910. In 1988, the party passed a resolution at its annual conference indicating when to use the full-form and short-form names: the full-form name was to be retained as the official name for use on legal documents and publication credits and the short form was to be used for most other purposes, including election ballots and propaganda. This is analogous to how the Conservative and Unionist Party publicises itself as the Conservative Party. The resolution was made partly to codify an existing practice and partly to avoid what some members considered the nationalistic connotation of Great Britain.
=== Climate === The climate of Jammu and Kashmir varies with altitude and across regions. Southern and southwestern areas have a sub-tropical climate, with hot summers and cool winters. This region receives most of its rainfall during the monsoon season. In the east and north, summers are usually pleasant. The effect of the monsoon diminishes in areas lying to the leeward side of the Pir Panjal, such as the Kashmir valley, and much of the rainfall happens in the spring season due to western disturbances. Winters are cold, with temperatures reaching sub-zero levels. Snowfall is common in the valley and the mountain areas.
Sources: en.wikipedia.org
=== First complete genomic nucleotide sequence === The 3569-nucleotide sequence of all of the genes of the RNA bacteriophage MS2 was determined by a large team of researchers over several years, and was reported in a series of scientific papers. These results enabled the analysis of the first complete genome, albeit an extremely tiny one by modern standards. Several surprising features were identified, including genes that partially overlap one another and the first clues that different organisms might have slightly different codon usage patterns.
=== Elections === In 1988, incumbent Republican congressman Jim Jeffords decided to run for the U.S. Senate, vacating the House seat representing Vermont's at-large congressional district. Former lieutenant governor Peter P. Smith won the House election with a plurality, securing 41% of the vote. Sanders, who ran as an independent, placed second with 38% of the vote, while Democratic state representative Paul N. Poirier placed third with 19%. Two years later, he ran for the seat again and defeated Smith by a margin of 56% to 39%. Sanders was the first independent elected to the U.S. House of Representatives since Frazier Reams of Ohio won his second term in 1952, as well as the first socialist elected to the House since Vito Marcantonio, from the American Labor Party, who won his last term in 1948. Sanders was a representative from 1991 until he became a senator in 2007, winning reelection by large margins except during the 1994 Republican Revolution, when he won by 3%, with 50% of the vote.
In October 2020, Nick Tarabay joined the cast as a series regular as Eclipso while Jonathan Cake was cast as Shade and Ysa Penarejo was cast in an undisclosed role in recurring capacities for the second season (later revealed to be Jennifer-Lynn Hayden / Jade, the daughter of Green Lantern), while Jim Gaffigan was cast as the voice of Thunderbolt. The following month, Alkoya Brunson was cast in a recurring role as Jakeem Thunder. In February 2021, John Wesley Shipp was revealed to be reprising his role as Jay Garrick from The Flash, albeit as an alternate version. Alex Collins replaced Thomas as Doctor Mid-Nite for the second season. Hopkins and Osmanski were promoted to series regulars for the third season in August 2021, following their recurring roles in the first season and guest appearance in the second. McHale was also promoted to a series regular in October for the third season following his guest appearances in the first two seasons. In March 2022, Tim Gabriel was cast as Todd Rice / Obsidian. In May, Seth Green joined the cast in recasting to succeed Gaffigan who voiced Thunderbolt last season. The third season trailer confirmed the return of Eric Goins as Steven Sharpe / Gambler, who appeared in the first but was absent from the second.
Acute toxicity The oral LD50 range of aflatoxin B1 is estimated to be 0.3–17.9 mg/kg body weight for most animal species. For instance, the oral LD50 of aflatoxin B1 is estimated to be 17.9 mg/kg body weight in female rats and 7.2 mg/kg body weight in male rats. Still in male rats, the intraperitoneal LD50 of aflatoxin B1 is estimated to be 6.0 mg/kg body weight. Symptoms include anorexia, malaise, and low-grade fever. Subacute toxicity Subacute toxicity studies of aflatoxin B1 in animals showed moderate to severe liver damage. In monkeys for instance, subacute toxicity studies showed portal inflammation and fatty change. Chronic toxicity Chronic toxicity studies of aflatoxin B1 in chickens showed decreased hepatic microsomal cytochrome P-450 concentration, reduction in feed consumption and decreased weight gain. Subchronic toxicity Subchronic toxicity studies of aflatoxin B1 in fish showed fish to present with preneoplastic lesions, concurrently with changes in gill, pancreas, intestine and spleen. Genotoxicity Treatment of human liver cells with aflatoxin B1 at doses that ranged from 3–5 μmol/L resulted in the formation of aflatoxin B1-DNA adducts, 8-hydroxyguanine lesions and DNA damage. Carcinogenicity The carcinogenicity of aflatoxin B1, which is characterized by the development of liver cell carcinoma, has been reported in rat studies. Embryotoxicity Embryonic death and impaired embryonic development of the bursa of Fabricius in chickens by aflatoxin B1 has been reported.
Elevated creatine kinase Leukocytosis Low serum iron These findings overlap with neuroleptic malignant syndrome (NMS). Therefore, it is essential to make careful correlation with clinical history, medications, and physical findings.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.